| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| FELLOWS EJ, BERNHEIM F |
The effect of a number of aralkylamines on the oxidation of tyramine b... |
J Pharmacol Exp Ther |
1950 |
| Delay J, Lhermitte F, Ver... |
Modifications de l'électrocorticogramme du lapin par la diéthylamide d... |
Rev. Neurol. |
1952 |
| Herxheimer H |
The 5-hydroxytryptamine shock in the guinea-pig. |
J. Physiol. |
1955 |
| Herxheimer H |
Bronchoconstrictor agents and their antagonists in the intact guinea-p... |
Arch. internat. phar... |
1956 |
| Wilhelmi G |
Ueber die ulcerogene Wirkung von 5-hydroxytryptamin am Rattenmagen und... |
Helvet. physiol et. ... |
1957 |
| Heim R, Brack A, Kobel H,... |
Déterminisme de la formation des carpophores et des sclèrotes dans la ... |
Compt. rend. Acad. s... |
1958 |
| Heim R, Hofmann A |
Isolement de la Psilocybine à partir du Stropharia cubensis Earle et d... |
Compt. rend. Acad. s... |
1958 |
| Delay J, Pichot P, Lempér... |
Effets psycho-physiologiques de la Psilocybine |
Comptes rendus des s... |
1958 |
| Hofmann A, Heim R, Brack ... |
Psilocybin ein psychotroper Wirkstoff aus dem mexikanischen Rauschpilz |
Rev. Mycologie |
1958 |
| Hofmann A, Heim R, Brack ... |
La Psilocybine, Principe Actif Psychotrope Extrait Du Champignon Hallu... |
Les chamignones hall... |
1958 |
| Heim R, Brack A, Kobel H,... |
Déterminisme de la formation des carpophores et des sclèrotes dans la ... |
Rev. Mycologie |
1958 |
| Heim R, Brack A, Kobel H,... |
Déterminisme de la formation des carpophores, et éventuellement des sc... |
Let champignons hall... |
1958 |
| Heim R, Hofmann A |
Isolement de la psilocybine à partir du Stropharia cubensis Earler et ... |
Rev. Mycologie |
1958 |
| Wilhelmi G, Schindler W |
Ueber die gastrotrope Wirkung von 5-Hydroxytryptamine (HTA), seiner Vo... |
Arch.exper.Path.Phar... |
1959 |
| Starbuck WC, Heim HD |
Some in vitro effects of chlorpromazine, lysergic acid diethylamide, a... |
J. Amer. Pharm. Ass.... |
1959 |
| Hofmann A, Heim R, Brack ... |
Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen... |
Helv. chim. Acta |
1959 |
| Heimann H |
Ausdrucksphanomenologie der Modellpsychosen (Psilocybin): Vergleich m... |
Psychiatria et Neuro... |
1961 |
| H Heimann |
Zur Behandlung therapieresistenter Neurosen mit Modellpsychosen (Psilo... |
Schweiz. Arch. Neuro... |
1962 |
| Heimann H |
Zur Behandlung therapieresistenter Neurosen mit Modellpsychosen (Psilo... |
Schweizer Archiv für... |
1962 |
| Heimann H |
Beobachtungen über gestörtes Zeiterleben in der Modellpsychose |
Schweiz. med. Wschr. |
1963 |
| Heimann H |
Die wirkung von ololiuqui im unterschied zu psilocybin |
Neuro-Psychopharmaco... |
1965 |
| Heimann H |
Die quantitative Analyse mimischer Bewegungen und ihre Anwendung in de... |
Arzneimittel-Forsch. |
1966 |
| Ruckebusch Y, Roche M, Sc... |
Parallélisme des effets des psychodysleptiques majeurs sur la toxicité... |
C.R. Soc. Biol. |
1966 |
| M Gyorgy Miklos Ola'h, He... |
Etude Chimiotaxinomique sur les Panaeolus. Recherches sur la presence ... |
C R Acad Sci |
1968 |
| Cheymol J |
Historique des hallucinogènes |
Laval Méd. |
1969 |
| Roche M |
Etude comparée des effets centraux des psychodysleptiques chez de lapi... |
C.R. Soc. Biol. |
1970 |
| Roche M |
Privation sensorielle et activité psychodysleptique |
C R Soc BIol (Paris) |
1970 |
| Heimann H |
Psychopharmakologie und Verhalten |
Fortibildungskurse d... |
1971 |
| Herman ZS |
5-Hydroxytptamine Metabolism in the Brain Under the Influence of Psych... |
Pol.J.Pharmacol.Phar... |
1975 |
| Chekman IS, Potemkina NN,... |
Nicotinamide Coenzymes as the Object of Action of Medicines and poison... |
Farmakol.Toksikol. |
1977 |
| Heym J, Steinfels GF, Jac... |
Medullary serotonergic neurons are insensitive to 5-MeoDMT and LSD |
European Journal of ... |
1982 |
| Jacobs BI, Heym J, Rasmus... |
Action of Hallucinogenic Drugs at Postsynaptic Serotonergic Receptors |
Psychopharmacology B... |
1982 |
| Glennon RA, Misenheimer B... |
Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopr... |
Pharmacol Biochem Be... |
1989 |
| Hekmatpanah CR, McKenna D... |
Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced n... |
Neurosci Lett |
1989 |
| Glennon RA, Misenheimer B... |
Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopr... |
Pharmacol Biochem Be... |
1989 |
| Glennon RA, Misenheimer B |
Stimulus properties of a new designer drug: 4-methylaminorex ('U4Euh') |
Pharmacol Biochem Be... |
1990 |
| Hekmatpanah CR, Peroutka ... |
5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-... |
Eur J Pharmacol |
1990 |
| Hermle L, Funfgeld M, Oep... |
Mescaline-induced psychopathological, neuropsychological, and neuromet... |
Biol Psychiatry |
1992 |
| Gouzoulis E, Steiger A, E... |
Sleep EEG effects of 3,4-methylenedioxyethamphetamine (MDE; "eve") in ... |
Biol Psychiatry |
1992 |
| Helmlin HJ, Brenneisen R |
Determination of psychotropic phenylalkylamine derivatives in biologic... |
J Chromatogr |
1992 |
| Gouzoulis E, Borchardt D,... |
A case of toxic psychosis induced by 'eve' (3,4-methylene-dioxyethylam... |
Arch Gen Psychiatry |
1993 |
| Hermle L, Spitzer M, Borc... |
Psychological effects of MDE in normal subjects. Are entactogens a new... |
Neuropsychopharmacol... |
1993 |
| Hermle L, Spitzer M, Borc... |
Psychological effects of MDE in normal subjects. Are entactogens a new... |
Neuropsychopharmacol... |
1993 |
| Gouzoulis E, von Bardeleb... |
Neuroendocrine and cardiovascular effects of MDE in healthy volunteers |
Neuropsychopharmacol... |
1993 |
| Cadet JL, Ladenheim B, Ba... |
CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to... |
Brain Res |
1994 |
| Cadet JL, Ladenheim B, Hi... |
Superoxide radicals mediate the biochemical effects of methylenedioxym... |
Synapse |
1995 |
| Cerruti C, Sheng P, Laden... |
Involvement of oxidative and L-arginine-NO pathways in the neurotoxici... |
Clin Exp Pharmacol P... |
1995 |
| Helmlin HJ, Bracher K, Bo... |
Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolit... |
J Anal Toxicol |
1996 |
| Wickremasinghe M |
Commentary. Ecstasy and crack cocaine |
Thorax |
1996 |
| Spitzer M, Thimm M, Herml... |
Increased activation of indirect semantic associations under psilocybi... |
Biol Psychiatry |
1996 |
| Rothe M, Pragst F, Spiege... |
Hair concentrations and self-reported abuse history of 20 amphetamine ... |
Forensic Sci Int |
1997 |
| Mann H, Ladenheim B, Hira... |
Differential toxic effects of methamphetamine (METH) and methylenediox... |
Brain Res |
1997 |
| Ensslin HK, Maurer HH, Go... |
Metabolism of racemic 3,4-methylenedioxyethylamphetamine in humans. Is... |
Drug Metab Dispos |
1997 |
| Van Cauter E, Plat L, Sch... |
Simultaneous stimulation of slow-wave sleep and growth hormone secreti... |
J Clin Invest |
1997 |
| Henman AR, Paone D, Des J... |
From ideology to logistics: the organizational aspects of syringe exch... |
Subst Use Misuse |
1998 |
| Plesan A, Hedman U, Xu XJ... |
Comparison of ketamine and dextromethorphan in potentiating the antino... |
Anesth Analg |
1998 |
| Gouzoulis-Mayfrank E, Hab... |
Hallucinogenic drug induced states resemble acute endogenous psychoses... |
Eur Psychiatry |
1998 |
| Henman AR, Paone D, Des J... |
Injection drug users as social actors: a stigmatized community's parti... |
AIDS Care |
1998 |
| Gouzoulis-Mayfrank E, Her... |
History, rationale and potential of human experimental hallucinogenic ... |
Pharmacopsychiatry |
1998 |
| Gouzoulis-Mayfrank E, The... |
Psychopathological, neuroendocrine and autonomic effects of 3,4-methyl... |
Psychopharmacology (... |
1999 |
| Jayanthi S, Ladenheim B, ... |
Overexpression of human copper/zinc superoxide dismutase in transgenic... |
Neuroscience |
1999 |
| Gouzoulis-Mayfrank E, Sch... |
Neurometabolic Effects of Psilocybin, 3,4-Methylenedioxyethylamphetami... |
Neuropsychopharmacol... |
1999 |
| Gouzoulis-Mayfrank E, Sch... |
Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetami... |
Neuropsychopharmacol... |
1999 |
| Grotenhermen F |
[Some practice-relevant aspects of the pharmacokinetics of THC] |
Forsch Komplementarm... |
1999 |
| Mann JJ, Huang YY, Underw... |
A serotonin transporter gene promoter polymorphism (5-HTTLPR) and pref... |
Arch Gen Psychiatry |
2000 |
| Quail MT, Weimersheimer P... |
Abuse of telazol: an animal tranquilizer |
J Toxicol Clin Toxic... |
2001 |
| Spitzer M, Franke B, Walt... |
Enantio-selective cognitive and brain activation effects of N-ethyl-3,... |
Neuropharmacology |
2001 |
| Decaestecker T, De Letter... |
Fatal 4-MTA intoxication: development of a liquid chromatographic-tand... |
J Anal Toxicol |
2001 |
| Thiriet N, Ladenheim B, M... |
Analysis of ecstasy (MDMA)-induced transcriptional responses in the ra... |
FASEB J |
2002 |
| Grotenhermen F |
Pharmacokinetics and pharmacodynamics of cannabinoids |
Clin Pharmacokinet |
2003 |
| Heim R |
Synthese und Pharmakologie potenter 5-HT2A-Rezeptoragonisten mit N-2-M... |
Doctoral Thesis |
2003 |
| Buechler J, Schwab M, Mik... |
Enantioselective quantitation of the ecstasy compound R- and S-N-ethyl... |
J Chromatogr B Analy... |
2003 |
| Marsicano G, Goodenough S... |
CB1 cannabinoid receptors and on-demand defense against excitotoxicity |
Science |
2003 |
| Fantegrossi WE, Woolverto... |
Behavioral and Neurochemical Consequences of Long-Term Intravenous Sel... |
Neuropsychopharmacol... |
2004 |
| Grotenhermen F |
How to prevent cannabis-induced psychological distress...in politician... |
Lancet |
2004 |
| Daumann J, Fischermann T,... |
Proton magnetic resonance spectroscopy in ecstasy (MDMA) users |
Neurosci Lett |
2004 |
| Daumann J Jr, Fischermann... |
Neural mechanisms of working memory in ecstasy (MDMA) users who contin... |
Biol Psychiatry |
2004 |
| Gouzoulis-Mayfrank E, Fis... |
Memory performance in polyvalent MDMA (ecstasy) users who continue or ... |
Drug and Alcohol Dep... |
2005 |
| Lee DY, Karnati VV, He M,... |
Synthesis and in vitro pharmacological studies of new C(2) modified sa... |
Bioorg Med Chem Lett |
2005 |
| Casteele SR, Bouche MP, V... |
LC-MS/MS in the elucidation of an isomer of the recreational drug meth... |
J Sep Sci |
2005 |
| Lachenmeier DW, Emmert J,... |
Thujone--cause of absinthism? |
Forensic Sci Int |
2006 |
| Padosch SA, Lachenmeier D... |
Absinthism: a fictitious 19th century syndrome with present impact |
Subst Abuse Treat Pr... |
2006 |
| Lachenmeier DW, Nathan-Ma... |
Systematic Misinformation about Thujone in Pre-ban Absinthe |
Deutsche Lebensmitte... |
2007 |
| Cheze M, Deveaux M, Marti... |
Simultaneous analysis of six amphetamines and analogues in hair, blood... |
Forensic Sci Int |
2007 |
| Lachenmeier DW, Nathan-Ma... |
Chemical composition of vintage preban absinthe with special reference... |
J Agric Food Chem |
2008 |
| Welsh C, Sherman SG, Tobi... |
A case of heroin overdose reversed by sublingually administered bupren... |
Addiction |
2008 |
| Meyer MR, Wilhelm J, Pete... |
Beta-keto amphetamines: studies on the metabolism of the designer drug... |
Anal Bioanal Chem |
2010 |
| Mason K, Cottrell AM, Cor... |
Ketamine-associated lower urinary tract destruction: a new radiologica... |
Clin Radiol |
2010 |
| Kapp FG, Maurer HH, Auwär... |
Intrahepatic cholestasis following abuse of powdered kratom (Mitragyna... |
J Med Toxicol |
2011 |
| Hermle L, Ruchsow M, Täsc... |
[Hallucinogen Persisting Perception Disorder (HPPD) and Flashback Phen... |
Fortschr Neurol Psyc... |
2015 |
| Petri G, Expert P, Turkhe... |
Homological scaffolds of brain functional networks |
J R Soc Interface |
2015 |
| Csete J, Kamarulzaman A, ... |
Public health and international drug policy |
Lancet |
2016 |
| Palamar JJ, Acosta P, She... |
Self-reported use of novel psychoactive substances among attendees of ... |
Am J Drug Alcohol Ab... |
2016 |
| Palamar JJ, Acosta P, Cal... |
Assessing self-reported use of new psychoactive substances: The impact... |
Am J Drug Alcohol Ab... |
2017 |
| Williams NR, Heifets BD, ... |
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor A... |
Am J Psychiatry |
2018 |
| Krieger MS, Goedel WC, Bu... |
Use of rapid fentanyl test strips among young adults who use drugs |
Int J Drug Policy |
2018 |
| Green TC, Park JN, Gilber... |
An assessment of the limits of detection, sensitivity and specificity ... |
International Journa... |
2020 |
| Maghsoudi N, Tanguay J, S... |
Drug checking services for people who use drugs: a systematic review |
Addiction |
2022 |
